Southwest’s buy-one-get-one-free flights, a Boeing strike, a new weight loss drug: Business news roundup
Business new tamfitronics
Southwest Airlines LUV is bringing back a promotion that lets customers bring a buddy for free. The company’s Companion Pass will allow members of its rewards program to access the feature.
Read More
BioAge Labs, a biopharmaceutical startup focused on obesity drugs and an Eli Lilly LLY collaborator, filed for an initial public offering on Tuesday, according to a filing with U.S. Securities and Exchange Commission.
Read More
According to Goldman Sachs GSthe best outcome of the 2024 election — for the U.S. economy — would be an overwhelming victory for Vice President Kamala Harris and her Democratic allies.
Read More
Even though its plate is otherwise very fullBoeing BA will also have to contend with another big item thrown onto it. As a contract with the union representing its machinists comes up for renewal, the company might soon have a strike on its hands.
Read More
Abbott Laboratories ABT launched today its first over-the-counter continuous glucose monitor aimed at consumers without diabetes.
The healthcare giant’s Lingo monitor is available without a prescription for $49 to consumers 18 years and older and who are not taking insulin.
Typically, continuous glucose monitors are used by people with diabetes to track their realtime blood-sugar levels. However, Abbott is targeting this new device at people who want to “improve their overall health and wellness.”
Read More
With NASA announcing that astronauts Butch Wilmore and Suni Williams will return to Earth next March on SpaceX’s Crew-9 mission, the focus quickly shifted to what will happen to the beleaguered Boeing Starliner. The space agency plans to autonomously undock the craft from the International Space Station but fears the Starliner could drift out of control and potentially crash into the station.
Read More
Novo Nordisk NGO said on Monday that a shortage of its popular diabetes drug Ozempic is expected to get worse this year.
“The supply situation for the lower strengths of Ozempic, 0.25 mg and 0.5 mg, has deteriorated with intermittent shortages for all strengths expected into Q4 2024,” the Danish pharma giant said a note published by the European Medicines Agency (EMA)the health regulator the European Union.
Read More
Nvidia stock is navigating one of its most turbulent weeks ever
The reported subpoena and Nvidia’s subsequent denial of it this week haven’t stopped the bleeding share price
California works to contain bird flu in its dairy farms
Cows at three California dairy farms have been placed under quarantine after testing positive for avian influenza, commonly known as bird flu